ID   OAW42-A
AC   CVCL_W125
SY   OAW42A
DR   CancerTools; 157984
DR   ECACC; 20082613
DR   Wikidata; Q54931686
RX   PubMed=8100138;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC=20082613
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 16,21
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1615 ! OAW42
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
RX   PubMed=8100138; DOI=10.1016/S0959-8049(05)80291-6;
RA   Redmond, Alice
RA   Moran, Elizabeth
RA   Clynes, Martin
RT   "Multiple drug resistance in the human ovarian carcinoma cell line
RT   OAW42-A.";
RL   Eur. J. Cancer 29A:1078-1081(1993).
//